📈 Revenue History (16 Quarters)
🧮 LMAT Revenue Breakdown
Understanding Revenue
Revenue, also called sales or the "top line," represents the total income a company generates from its business activities before any costs are deducted. For LMAT, the trailing twelve month revenue is $262.4M.
Why Revenue Matters
Revenue is the foundation of all financial analysis. A company cannot have sustainable profits without revenue, and revenue growth often drives stock price appreciation. However, revenue alone doesn't tell the full story - it must be analyzed alongside profitability metrics.
LMAT's revenue growth rate of 15.25% (based on log-linear regression of 16 quarters) indicates healthy growth above the market average.
Revenue vs Profitability Metrics
Free Cash Flow: $79.1M →
The cash remaining after capital expenditures. High revenue with negative FCF may indicate heavy reinvestment or poor cash conversion.
Owner Earnings: $79.3M →
Buffett's metric for true cash generation. Compares revenue's conversion to actual owner value.
Earnings Per Share: $2.86 →
Net income per share. The bottom line result of all revenue after costs, taxes, and interest.
Net Income: $65.7M
What remains after all expenses. Net margin shows what percentage of revenue becomes profit.
Price/Sales Ratio Analysis
LMAT's P/S ratio of 7.0x means investors pay $7.01 for every $1 of annual revenue. A P/S between 3-10 suggests investors expect continued growth and margin expansion.
Gross Margin: Revenue Quality
Gross margin of 72.90% shows how much of LMAT's revenue remains after direct costs. High gross margins above 60% often indicate strong pricing power, brand value, or intellectual property moats.
Summary: LMAT Revenue Trend
LEMAITRE VASCULAR, INC. (LMAT) generated $262.4M in trailing twelve-month revenue, growing at 15.25% annually — above the 10% threshold Zyberno considers healthy growth above market averages. LEMAITRE VASCULAR, INC.'s gross margin of 72.90% is excellent for a Healthcare company — above the 60% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins, a level typically associated with strong pricing power and durable competitive advantages. For complete financial analysis, view the full LMAT stock report on Zyberno.
Frequently Asked Questions
What is LMAT's current revenue?
LEMAITRE VASCULAR, INC.'s trailing twelve month (TTM) revenue is $262.4M, growing at 15.25% annually — above the 10% threshold Zyberno considers healthy growth above market averages.
Is LMAT's revenue growing?
LEMAITRE VASCULAR, INC. (LMAT) generated $262.4M in trailing twelve-month revenue, growing at 15.25% annually — above the 10% threshold Zyberno considers healthy growth above market averages. LEMAITRE VASCULAR, INC.'s gross margin of 72.90% is excellent for a Healthcare company — above the 60% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins, a level typically associated with strong pricing power and durable competitive advantages.
What is LMAT's gross margin?
LEMAITRE VASCULAR, INC.'s gross margin of 72.90% is excellent for a Healthcare company — above the 60% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins, a level typically associated with strong pricing power and durable competitive advantages.
What is LMAT's Price/Sales ratio?
LMAT's P/S ratio is 7.0x, meaning the market values the company at 7.0 times its annual revenue.
How does revenue differ from profit?
Revenue is the total income before any expenses, while profit (net income) is what remains after all costs. LMAT's revenue is $262.4M with a net income of $65.7M, showing a net profit margin of 25.0%.
📊 Full LMAT Stock Report →
See LMAT's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.
💵 LMAT Free Cash Flow →
Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.
💰 LMAT Owner Earnings →
Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.
📈 LMAT Earnings Per Share →
Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.
🎯 LMAT Earnings Surprise (SUE) →
See whether LMAT is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.
📊 LMAT Revenue →
Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.
💰 LMAT Net Income →
Analyze the bottom-line profit, P/E ratio, and net profit margin trends.
🔶 LMAT Operating Income →
Analyze EBIT, operating margin, and core business profitability before interest and taxes.
💜 LMAT Gross Profit →
Analyze gross margin, pricing power, and profitability before operating expenses.